Insider · CIK 0001513422
Daniella Beckman
Files at BPMC (Blueprint Medicines Corp), VOR (Vor Biopharma Inc.), TNGX (Tango Therapeutics, Inc.), UPB (Upstream Bio, Inc.). First filing Feb 6, 2025, latest Feb 6, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TNGX: Tango Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Tango Therapeutics, Inc. | $25k 8,232 shares | -5% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | BPMC Blueprint Medicines Corp | AGrant or award Common Stock | +3,902 | $128.12 | $500k | 14,744 | Jun 24, 2025 |
| Jun 10, 2025 | UPB Upstream Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,096 | $0.00 | $0 | 17,096 | Jun 12, 2025 |
| May 22, 2025 | VOR Vor Biopharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | May 23, 2025 |
| Feb 4, 2025 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock | -4,284 | $2.99 | $13k | 154,232 | Feb 6, 2025 |
| Feb 5, 2025 | TNGX Tango Therapeutics, Inc. | SOpen-market sale Common Stock | -3,948 | $3.16 | $12k | 150,284 | Feb 6, 2025 |
| Feb 3, 2025 | TNGX Tango Therapeutics, Inc. | AGrant or award Common Stock | +26,119 | $0.00 | $0 | 158,516 | Feb 5, 2025 |
| Feb 3, 2025 | TNGX Tango Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +156,713 | $0.00 | $0 | 156,713 | Feb 5, 2025 |
| Oct 10, 2024 | UPB Upstream Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +34,681 | $0.00 | $0 | 34,681 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.